Abstract:An efficient radiotherapeutic agent is synthesized using ultrathin two-dimensional 30-nm-wide and 2-nm-thick Bi2Se3 nanosheets (NSs) as a radiosensitizer. Chitosan (CS) and RGD peptide are employed to enhance the radiotherapy efficiency and biocompatibility. The Bi2Se3-CS-RGD NSs exhibit excellent targeting ability to αvβ3 integrin-overexpressing cancer cells and potent radiosensitization efficiency with high stability. Detailed in vitro experiments show that the Bi2Se3-CS-RGD NSs enhance the sensitivity of HeLa cells to X-ray-induced cell death by inhibiting TrxR activities and activating downstream reactive oxygen species-mediated signaling pathways. In vivo experiments using intravenous or intratumor injection demonstrate that the Bi2Se3-CS-RGD NSs are more efficient tumor growth inhibitors compared to bare Bi2Se3 NSs. The multifunctionality of the NSs enables the use of photoacoustic imaging and magnetic resonance imaging to examine their targeting ability and therapeutic effects, respectively. In addition, the RGD-decorated Bi2Se3 NSs show much better in vivo biocompatibility and can be efficiently expelled from the body after 48 h post injection. This study reveals an effective and safe theranostic agent for next-generation cancer radiotherapy. A nanomaterial that enhances the targeted destruction of cancer cells by radiotherapy has been demonstrated by scientists in China. Radiotherapy uses X-rays to destroy cancerous cells, but some cancers are not sensitive to X-rays. Injecting an agent into the body that binds to cancer cells can make them more sensitive, but it is difficult to make such agents on large scales. Tianfeng Chen from Jinan University in Guangzhou and co-workers combined two-dimensional sheets of bismuth selenide with chitosan and a peptide to create a biocompatible material that enhances radiotherapy efficiency. The material shows excellent ability to target cancer cells and has a potent radiosensitization efficiency with high stability. Furthermore, it has good biocompatibility and is efficiently expelled from the body efficiently after injection. Ultrathin Bi2Se3-CS-RGD NSs with excellent tumor-targeting ability and potent radiosensitization efficiency are constructed for imaging-guided cancer radiotherapy. The NSs in combination with X-ray irradiation inhibit HeLa cell growth by inducing G0/G1 cycle arrest and mitochondria-mediated intrinsic cell apoptosis, inhibiting TrxR and activating downstream ROS-mediated signaling pathways. Moreover, RGD coating enables the NSs to aggregate in the tumor regions quickly enabling efficient PAI of the entire tumor to facilitate radiotherapy of cervical cancer. Taken together, this study provides an effective and safe theranostic agent for next-generation cancer radiotherapy.

Photothermal Killing of A549 Cells and Autophagy Induction by Bismuth Selenide Particles

Bismuth Embedded Silica Nanoparticles Loaded with Autophagy Suppressant to Promote Photothermal Therapy.

Bacteria-Mediated Ultrathin Bi2Se3 Nanosheets Fabrication and Their Application in Photothermal Cancer Therapy

Improving the Photothermal Therapy Efficacy and Preventing the Surface Oxidation of Bismuth Nanoparticles Through the Formation of a Bismuth@bismuth Selenide Heterostructure

Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy

Bismuth@Bismuth Sulfide Core@Shell Structure for Near Infrared II Light Triggered Photothermal Therapy

CD47-targeted Bismuth Selenide Nanoparticles Actualize Improved Photothermal Therapy by Increasing Macrophage Phagocytosis of Cancer Cells.

Multimodal Imaging-Guided Antitumor Photothermal Therapy and Drug Delivery Using Bismuth Selenide Spherical-Sponge.

Biodegradable Bismuth Nanostructures As a Ferroptosis Inducer for Phototherapy of Breast Cancer

Decorated Ultrathin Bismuth Selenide Nanosheets As Targeted Theranostic Agents for in Vivo Imaging Guided Cancer Radiation Therapy

Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging

Metabolizable Bi2Se3 Nanoplates: Biodistribution, Toxicity, and Uses for Cancer Radiation Therapy and Imaging

Metabolizable Ultrathin Bi2Se3 Nanosheets in Imaging‐Guided Photothermal Therapy

Acid-Responsive Bismuth Heterojunction Nanocatalyst for Photocatalytic and Photothermal Treatment of Tumors

Metabolizable Bi 2 Se 3 Nanoplates: Biodistribution, Toxicity, and Uses for Cancer Radiation Therapy and Imaging

Cell-borne 2D nanomaterials for efficient cancer targeting and photothermal therapy

Immune-adjuvant loaded Bi 2 Se 3 nanocage for photothermal-improved PD-L1 checkpoint blockade immune-tumor metastasis therapy

Photothermal and Enhanced Photocatalytic Therapies Conduce to Synergistic Anticancer Phototherapy with Biodegradable Titanium Diselenide Nanosheets

Mesoporous Silica-Coated Bismuth Nanohybrids As a New Platform for Photoacoustic/computed Tomography Imaging and Synergistic Chemophotothermal Therapy

Photocatalytic and photothermal bismuthene nanosheets as drug carrier capable of generating CO to improve drug sensitivity and reduce inflammation for enhanced cancer therapy

Core–Shell Bi2Se3@mSiO2‐PEG As a Multifunctional Drug‐Delivery Nanoplatform for Synergistic Thermo‐Chemotherapy with Infrared Thermal Imaging of Cancer Cells